(1) What is the current level of collaboration between the Human Sciences Research Council (HSRC) and the SA National Space Agency (SANSA); (2) is the HSRC currently benefitting from preferential pricing from any of SANSA’s products and services with regard to (a) spatial development and migration, (b) HIV/Aids and sexually transmitted diseases and (c) Tuberculosis; if not, why not in each case; if so, what are the relevant details of the specified benefits in each case?